<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=1981844" created="06/04/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>1981844</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="human_immunodeficiency_virus_type-2_gene_expression" sem="Other"><term id="A5" sem="DNA_domain_or_region"><term id="T2" lex="human_immunodeficiency_virus_type-2" sem="Virus"><term id="T3" lex="human_immunodeficiency_virus" sem="Virus">Human immunodeficiency virus</term> type-2</term> gene</term> expression</term>: two <term id="T4" lex="enhancer" sem="DNA_domain_or_region">enhancers</term> and their activation by <term id="T5" lex="T-cell_activator" sem="Other"><term id="T6" lex="T-cell" sem="Cell_natural">T-cell</term> activators</term>.</sentence>
<event KT="Investigation" id="E1">
<type class="Gene_expression"/>
<theme idref="A5"/>
<clue>Human immunodeficiency virus type-2 gene <clueType>expression</clueType>: two enhancers and their activation by T-cell activators.</clue>
</event>
<event KT="Investigation" id="E2">
<type class="Positive_regulation"/>
<theme idref="T4"/>
<cause idref="T5"/>
<clue>Human immunodeficiency virus type-2 gene expression: two enhancers and their <clueType>activation</clueType> <linkCause>by</linkCause> T-cell activators.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The <term id="T7" lex="human_immunodeficiency_virus" sem="Virus">human immunodeficiency viruses</term> (<term id="T8" lex="HIV" sem="Virus">HIVs</term>) may include a spectrum of <term id="T9" lex="retrovirus" sem="Virus">retroviruses</term> with varying potential to infect their <term id="A1" sem="Multicellular_organism_natural">host</term>, undergo long periods of <term id="T10" lex="latent_infection" sem="Other">latent infection</term>, and induce <term id="T11" lex="pathology" sem="Other">pathology</term>.</sentence>
<event CL="L1" KT="Analysis" id="E3">
<type class="Initiation_of_viral_infection"/>
<theme idref="A1"/>
<theme idref="T8"/>
<clue>The human immunodeficiency viruses (HIVs) may include a spectrum of retroviruses with varying <clueKT><clueCL>potential to</clueCL></clueKT> <clueType>infect</clueType> their host, undergo long periods of latent infection, and induce pathology.</clue>
</event>
<event CL="L1" KT="Analysis" id="E20">
<type class="Positive_regulation"/>
<theme idref="T10"/>
<cause idref="T8"/>
<clue>The human immunodeficiency viruses (HIVs) may include a spectrum of retroviruses with varying <clueKT><clueCL>potential to</clueCL></clueKT> infect their host, <clueType>undergo</clueType> long periods of latent infection, and induce pathology.</clue>
</event>
<event CL="L1" KT="Analysis" id="E21">
<type class="Positive_regulation"/>
<theme idref="T11"/>
<cause idref="T8"/>
<clue>The human immunodeficiency viruses (HIVs) may include a spectrum of retroviruses with varying <clueKT><clueCL>potential to</clueCL></clueKT> infect their host, undergo long periods of latent infection, and <clueType>induce</clueType> pathology.</clue>
</event>
<sentence id="S3">Since expression of the <term id="A2" sem="DNA_domain_or_region">viruses</term> is in large part regulated by the <term id="T12" lex="sequence_element" sem="DNA_domain_or_region">sequence elements</term> in their <term id="T13" lex="long_terminal_repeat" sem="DNA_domain_or_region">long terminal repeats</term> (<term id="T14" lex="LTR" sem="DNA_domain_or_region">LTRs</term>), this study was directed to an analysis of the <term id="T15" lex="regulatory_element" sem="DNA_family_or_group">regulatory elements</term> in the <term id="T16" lex="HIV-2_LTR" sem="DNA_domain_or_region"><term id="T17" lex="HIV-2" sem="Virus">HIV-2</term> LTR</term>.</sentence>
<event KT="Other" id="E4">
<type class="Gene_expression"/>
<theme idref="A2"/>
<clue>Since <clueType>expression</clueType> <linkTheme>of</linkTheme> the viruses is in large part regulated by the sequence elements in their long terminal repeats (LTRs), this study was directed to an analysis of the regulatory elements in the HIV-2 LTR.</clue>
</event>
<event KT="Fact" id="E5">
<type class="Regulation"/>
<theme idref="E4"/>
<cause idref="T14"/>
<clue>Since expression of the viruses is in large part <clueType>regulated</clueType> <linkCause>by</linkCause> the sequence elements in their long terminal repeats (LTRs), this study was directed to an analysis of the regulatory elements in the HIV-2 LTR.</clue>
</event>
<sentence id="S4">The <term id="T18" lex="HIV-2_LTR" sem="DNA_domain_or_region"><term id="T19" lex="HIV-2" sem="Virus">HIV-2</term> LTR</term> was found to contain two <term id="T20" lex="enhancer" sem="DNA_domain_or_region">enhancers</term>.</sentence>
<sentence id="S5">One of these <term id="T21" lex="enhancer" sem="DNA_domain_or_region">enhancers</term> is, in part, identical to the <term id="T22" lex="HIV-1_enhancer" sem="DNA_domain_or_region"><term id="T23" lex="HIV-1" sem="Virus">HIV-1</term> enhancer</term>.</sentence>
<sentence id="S6">This <term id="T24" lex="enhancer" sem="DNA_domain_or_region">enhancer</term> in <term id="T25" lex="HIV-1" sem="Virus">HIV-1</term> is the <term id="T26" lex="T-cell_activation_response_element" sem="DNA_domain_or_region"><term id="T27" lex="T-cell_activation" sem="Other"><term id="A6" sem="Cell_natural">T-cell</term> activation</term> response element</term>; in <term id="T28" lex="HIV-2" sem="Virus">HIV-2</term>, however, it is the <term id="T29" lex="second_enhancer" sem="DNA_domain_or_region">second enhancer</term> that is mainly responsible for activation in response to <term id="T30" lex="T-cell_activator" sem="Other">T-cell activators</term>.</sentence>
<event id="E7">
<type class="Physiological_process"/>
<theme idref="A6"/>
<cause idref="T30"/>
<clue>This enhancer in HIV-1 is the T-cell activation response element; in HIV-2, however, it is the second enhancer that is mainly responsible for <clueType>activation</clueType> <linkCause>in response to</linkCause> T-cell activators.</clue>
</event>
<event id="E8">
<type class="Regulation"/>
<theme idref="E7"/>
<cause idref="T29"/>
<clue>This enhancer in HIV-1 is the T-cell activation response element; <clueLoc>in HIV-2</clueLoc>, however, it is the second enhancer that is mainly <clueType>responsible</clueType> <linkTheme>for</linkTheme> activation in response to T-cell activators.</clue>
</event>
<sentence id="S7">The second <term id="T31" lex="enhancer" sem="DNA_domain_or_region">enhancer</term> interacts with two <term id="T32" lex="nuclear_binding_protein" sem="Protein_family_or_group">nuclear binding proteins</term> (<term id="A3" sem="Protein_family_or_group">85 kD</term> and <term id="A4" sem="Protein_family_or_group">27 kD</term> mobility) that appear to be required for optimal <term id="T33" lex="enhancer_function" sem="Other">enhancer function</term> and activation.</sentence>
<event CL="L2" KT="Analysis" id="E9" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="T33"/>
<cause idref="A3" idref1="T32"/>
<clue>The second enhancer interacts with two nuclear binding proteins (85 kD and 27 kD mobility) that <clueKT><clueCL>appear</clueCL></clueKT> to be <clueType>required</clueType> <linkTheme>for</linkTheme> optimal enhancer function and activation.</clue>
</event>
<event CL="L2" KT="Analysis" id="E10" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E11"/>
<cause idref="A3" idref1="T32"/>
<clue>The second enhancer interacts with two nuclear binding proteins (85 kD and 27 kD mobility) that <clueKT><clueCL>appear</clueCL></clueKT> to be <clueType>required</clueType> <linkTheme>for</linkTheme> optimal enhancer function and activation.</clue>
</event>
<event KT="Other" id="E11">
<type class="Positive_regulation"/>
<theme idref="T31"/>
<clue>The second enhancer interacts with two nuclear binding proteins (85 kD and 27 kD mobility) that appear to be required for optimal enhancer function and <clueType>activation</clueType>.</clue>
</event>
<event CL="L2" KT="Analysis" id="E12" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="T33"/>
<cause idref="A4" idref1="T32"/>
<clue>The second enhancer interacts with two nuclear binding proteins (85 kD and 27 kD mobility) that <clueKT><clueCL>appear</clueCL></clueKT> to be <clueType>required</clueType> <linkTheme>for</linkTheme> optimal enhancer function and activation.</clue>
</event>
<event CL="L2" KT="Analysis" id="E13" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E11"/>
<cause idref="A4" idref1="T32"/>
<clue>The second enhancer interacts with two nuclear binding proteins (85 kD and 27 kD mobility) that <clueKT><clueCL>appear</clueCL></clueKT> to be <clueType>required</clueType> <linkTheme>for</linkTheme> optimal enhancer function and activation.</clue>
</event>
<event id="E14">
<type class="Binding"/>
<theme idref="T31"/>
<theme idref="A3" idref1="T32"/>
<clue>The second enhancer <clueType>interacts</clueType> <linkTheme>with</linkTheme> two nuclear binding proteins (85 kD and 27 kD mobility) that appear to be required for optimal enhancer function and activation.</clue>
</event>
<event id="E15">
<type class="Binding"/>
<theme idref="T31"/>
<theme idref="A4" idref1="T32"/>
<clue>The second enhancer <clueType>interacts</clueType> <linkTheme>with</linkTheme> two nuclear binding proteins (85 kD and 27 kD mobility) that appear to be required for optimal enhancer function and activation.</clue>
</event>
<sentence id="S8">Observations such as these encourage the speculation that there may be subtle differences in the <term id="T34" lex="regulation" sem="Other">regulation</term> of <term id="A20" sem="DNA_domain_or_region"><term id="T35" lex="HIV-1" sem="Virus">HIV-1</term></term> and <term id="T36" lex="HIV-2_expression" sem="Other"><term id="A21" sem="DNA_domain_or_region"><term id="T37" lex="HIV-2" sem="Virus">HIV-2</term></term> expression</term> that may be relevant to the possible longer <term id="T38" lex="latency" sem="Other">latency</term> and reduced pathogenicity of <term id="T39" lex="HIV-2" sem="Virus">HIV-2</term>.</sentence>
<event KT="Other" id="E16">
<type class="Gene_expression"/>
<theme idref="A20"/>
<clue>Observations such as these encourage the speculation that there may be subtle differences in the regulation of HIV-1 and HIV-2 <clueType>expression</clueType> that may be relevant to the possible longer latency and reduced pathogenicity of HIV-2.</clue>
</event>
<event KT="Other" id="E17">
<type class="Gene_expression"/>
<theme idref="A21"/>
<clue>Observations such as these encourage the speculation that there may be subtle differences in the regulation of HIV-1 and HIV-2 <clueType>expression</clueType> that may be relevant to the possible longer latency and reduced pathogenicity of HIV-2.</clue>
</event>
<event KT="Other" id="E18">
<type class="Regulation"/>
<theme idref="E16"/>
<clue>Observations such as these encourage the speculation that there may be subtle differences in the <clueType>regulation</clueType> <linkTheme>of</linkTheme> HIV-1 and HIV-2 expression that may be relevant to the possible longer latency and reduced pathogenicity of HIV-2.</clue>
</event>
<event KT="Other" id="E19">
<type class="Regulation"/>
<theme idref="E17"/>
<clue>Observations such as these encourage the speculation that there may be subtle differences in the <clueType>regulation</clueType> <linkTheme>of</linkTheme> HIV-1 and HIV-2 expression that may be relevant to the possible longer latency and reduced pathogenicity of HIV-2.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
